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Background: No guidelines comprise when or to what extent sinus surgery should be done in patients with cystic ﬁbrosis (CF) or how a CT scan of
the paranasal sinuses should inﬂuence the decision. Symptoms of rhinosinusitis and/or eradication of pathogenic bacteria from the sinuses are rea-
sons for sinus surgery.
Methods: In this observational cross sectional study, 55 CF cases had their preoperative CT scans scored according to the Lund Mackay- and the
Nair-system. Correlations between the CT scans, symptoms, surgical ﬁndings and cultures obtained during sinus surgery were made.
Results: There was no signiﬁcant correlation between the CT score and detection of pus, pathogenic bacteria or symptoms. Pus and pathogenic
bacteria were found in several cases without sinus opaciﬁcation on the CT scan. Non pathogenic and sterile cultures were also found in sinuses
with opaciﬁcation.
Conclusions: A CT scan is not a valid criterion for sinus surgery in CF patients.
© 2011 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Rhinosinusitis; Sinus surgery; CT scan; Nair score; Cystic ﬁbrosis; Bacteriology1. Introduction
Nasal and sinus mucosal disease are by definition present in
patients with cystic fibrosis (CF) because of defective CFTR-
channels in the sinonasal mucosa, as found in the lower CF air-
ways [1]. Apart from viscous mucus, common findings are
nasal congestion, polyposis, mucoceles, mucopurulent material,
medial bulging of the maxillary walls, ostitis and aplasia of the
paranasal sinuses especially of the frontal sinus [2,3] Abnormal
anatomy increases the risk of complications during sinus surgery.
Magnetic resonance imaging (MRI) or CT scans can visualise the
anatomy, alterations in the patency and the opacification of the si-
nuses [3–6]. A CT scan or MRI is mandatory prior to sinus⁎ Corresponding author. Tel.: +45 35 45 86 91.
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doi:10.1016/j.jcf.2011.09.009surgery in CF patients but show limitations in predicting outcome
of the surgery in non-CF patients [1,7]. The Lund Mackay scor-
ing system is commonly used when describing CT scans of the
paranasal sinuses [1,8]. The Nair scoring system can also be
used but differs from the Lund Mackay by including the amount
of opacification in the score [9].
According to the European Position Paper on Rhinosinusitis
and Nasal Polyposis (EPOS) sinus surgery is indicated in non-
CF patients with chronic rhinosinusitis (CRS) after failure of
medical treatment [1]. Medical treatment is the primary therapy
in CF patients with symptoms of CRS as well, but no guidelines
exist comprising criteria for sinus surgery in CF patients if med-
ical treatment is unsuccessful [1,10]. In 2007 we changed our
sinonasal treatment strategy for CF patients towards offering
Computer-Assisted Functional Endoscopic Sinus Surgery (CAS
FESS) as a supplementary tool to diagnose and attempting to
eradicate putative bacterial sinus infections. This was doneby Elsevier B.V. All rights reserved.
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was gradually recognised [11]. The preoperative CT scans were
used for pre-surgical planning and guidance, but not as a criterion
for FESS, which is in contrast to the role of CT in non-CF pa-
tients, in whom CT findings of the sinuses correlates with
the severity of CRS [12] and represents one of the criteria in setting
the CRS-diagnosis [1]. CF patients show less correlation between
the radiological findings and symptoms compared with non-CF
CRS patients [13].
We investigated the correlation between CT scans, CRS
symptoms, surgical findings and cultured materials collected
during sinus surgery in CF patients, in order to determine
whether CT scans should be included as a criterion for sinus
surgery in CF patients.
2. Materials and methods
2.1. Patients
Patients from CF-centre Copenhagen, with a CF-diagnosis
based on characteristic clinical features, abnormal sweat elec-
trolytes and genotype, who underwent sinus surgery during
the period of January 2007 to February 2010 were eligible to
this observational, cross sectional study. Only patients with a
CT scan of the paranasal sinuses performed less than 3 months
prior to surgery were included. If patients had revision surgery,
each surgery counted as one case. Patients were prioritised for
CAS FESS based on the following three criteria ranked accord-
ing to importance:
1 Intermittently lung colonised patients with a prolonged declin-
ing lung function, despite intensive antibiotic-chemotherapy,
and/or increasing antibodies against Gram-negative bacteria.
Especially patients with an unknown focus and increasing an-
tibodies against Pseudomonas aeruginosa, Achromobacter
xylosoxidans or Burkholderia cepacia complex were given
priority.
2 Patients who have had lung transplantationwere offered surgery
within the first year following the transplantation.
3 Patients with severe symptoms of CRS in accordance with
the EPOS guidelines.
Current treatments with corticosteroids or immunosuppres-
sive agents (PO 6 weeks and IV 1 week prior to the CT scan)
were registered since these factors are known to influence the
mucosal lining in the sinuses. Treatment with topical corticoste-
roids was not registered. According to lung bacteriology and
precipitating antibodies (normal values 0–1) [14], the patients
were categorised as intermittently colonised or chronically infected
with Gram-negative bacteria at the time of surgery [14,15]. The
overall treatment strategy at the CF Centre Copenhagen is de-
scribed in detail elsewhere [16,17].
2.2. CT scans
CT scans were performed in supine position. Slice thickness:
0.5–2.0 mm. No contrast was given. The CT scans were usedfor pre-surgical planning and as image guidance during surgery.
The CT scans were retrospectively reviewed and assessed accord-
ing to the Lund Mackay and the Nair systems [8,9].
The Lund Mackay system grades each sinus with either
0: no opacification, 1: some opacification or 2: total opacification.
The Nair system grades each sinus with either 0: no opacification,
1: less than 25% opacification, 2: between 25% and 50%opacifica-
tion or 3: more than 50% opacification. The Lund Mackay system
also differs from the Nair system by distinguishing between the
anterior and the posterior ethmoid sinuses. Both scoring systems
have a range of 0–24 as the Nair system does not score the osteo-
meatal complex.2.3. Surgical procedures
Patients were anaesthetised using total intravenous anaesthesia.
No local disinfectants were used in the nose. Three experienced
surgeons performed the operations. The purpose was to create
ventilation and drainage pathways for the sinuses allowing postop-
erative instrumental and medical irrigations. The principle of the
surgical procedure was performed as a classical FESS comprising
an uncinectomy, an anterior ethmoidectomy and a medial antrost-
omy enlarging the natural maxillary ostium. The opened sinuses
where explored and cultured leaving an enlarged ostium accessi-
ble for drainage and ventilation. The operation was finished on
one side before operating on the other side, to avoid bacterial con-
tamination from one nasal cavity to the other. Each patient was
thoroughly evaluated with regards to their CT scan, symptoms,
and clinical examination; based on these findings the decision re-
garding the extension of the surgery, covering a putative concha
bulosa, the posterior ethmoids, the sphenoid and the frontal si-
nuses or if septum deviations were to be corrected, was made.
To optimise culture results multiple samples were prioritised
including nasal secretions, pus, mucosal tissue, polyps, and
bone. These samples were collected with sharp instruments or
by suction. Following the surgical procedure the nasal cavities
were irrigated with saline and colistin.
The surgical findings in each sinus were categorised in four
groups according to the surgeons' descriptions. 1: unknown,
the sinus was not opened; 2: the sinus was not developed; 3:
macroscopically purulent material was described; 4: no macro-
scopically purulent material was described.2.4. Microbiological samples
The material from the operation was immediately cultured in
the microbiology laboratory. Gram-stained smears and aerobic
cultures on selective media were performed on all samples.
These media include a Sabouraud plate, a 7% NaCl plate, a
B. cepacia plate containing colistin and gentamicin, a “blue
plate” (modified Conradi Drigalski's medium) selective for
Gram-negative rods and non-selective media including 5%
Danish blood agar and chocolate agar (State Serum Institute,
Copenhagen, Denmark). Isolated bacteria were identified as
previously described [18]. Direct plating of tissue samples
and pus on a 14 cm blood agar plate with discs containing
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testing (Rosco® Neosensitabs) [18].
We divided the culture-results from each sinus into four
groups: 1) “no culture” where no samples were obtained; 2)
“pathogenic growth” containing bacteria or fungus from the si-
nuses that are considered pathogenic for CF patients comprising
P. aeruginosa, A. xylosoxidans, Burkholderia multivorans,
Stenotrophomonas maltophilia, Staphylococcus aureus,
Bordetella bronchiseptica, Haemophilus influenzae and As-
pergillus species; 3) “non pathogenic growth” containing or-
ganisms that are not likely to serve as a reservoir and
causing CF lung infections comprising Escherichia coli,
Enterobacter cloacae, Candida albicans and Coagulase neg-
ative staphylococci; 4) “no growth after culture”.
2.5. Symptom score
From 2009, it has become standard for all CF patients to pre-
surgical complete a validated questionnaire about symptoms
and social/emotional consequences of their rhinosinusitis scor-
ing from 0 to a maximum of 110 points (SNOT-22) [19]. No0
1
2
3
4
5
6
7
Lund
Fr
eq
ue
nc
y
0
1
2
3
4
5
6
7
8
0 1 2 3 4 5 6 7 8 9 10 11
0 1 2 3 4 5 6 7 8 9 10 11
Nair
Fr
eq
ue
nc
y
B
A
Fig. 1. A: The opacification according to the Nair staging. B:additional systemic antibiotic or steroid treatments were given
in relation to surgery, which could have influenced the symp-
tom scores.2.6. Data and statistics
The data were processed blinded; the radiologist who staged
the CT scans had no access to the patient files or to the results
from the cultured samples. The laboratory technician who cul-
tured the sinus material had no knowledge of the CT scans or
the surgical findings. The physician who noted the operative
findings according to the patient files had no access to the CT
scans or to the results of the cultured material. After the data
were processed, the findings of the CT scans were compared
with the operative findings and the outcome of the cultured
samples. The statistics were made in SAS 9.1.3. Since especial-
ly the Nair scoring results do not follow a normal distribution
(Fig. 1A), the inter-quartile range (IQR) was used to describe
the spread, although mean values were used to evaluate the cor-
relation between CT scores and bacteriology. The correlation Score
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12 13 14 15 16 17 18 19 20 21 22 23 24
 Score
The opacification according to the Lund Mackay staging.
Table 2
The culture results distributed on the different sinuses.
No
culture
no. (%)
Pathogenic
growth no.
(%)
Non-pathogenic
growth no. (%)
No
growth
no. (%)
Total
Maxillaries 6 (5.5) 67 (60.9) 33 (30.0) 4 (3.6) 110
Ethmoids 84 (38.2) 90 (40.9) 32 (14.5) 14 (6.4) 220
Frontals 91 (85.8) 11 (10.0) 3 (2.7) 1 (0.9) 106
Sphenoids 97 (89.8) 7 (6.4) 3 (2.7) 1 (0.9) 108
Total 278 (51.1) 175 (31.8) 71 (12.9) 20 (3.6) 544
Table 3
A list of all pathogenic (pat.) and non-pathogenic (non-pat.) micro-organisms
found at surgery and in how many, out of the 55 cases, they were found. It
should be noted that 27 out of 55 cases had P. aeruginosa and that the data
are cumulative since one case can host more than one microorganism.
Bacteria Number of cases
Pseudomonas aeruginosa (pat.) 27
Achromobacter xylosoxidans (pat.) 7
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ple linear regression.
3. Results
3.1. Patients
Eighty-five cases of sinus surgery on CF patients were per-
formed. Forty-eight patients were CT scanned within 3 months
prior to surgery and seven of these patients underwent surgery
twice, leaving a total of 55 cases in the study. Fifteen patients
were chronically lung infected (ten with P. aeruginosa, three
with A. xylosoxidans and three with B. multivorans) and 33 pa-
tients were intermittently colonised with Gram-negative bacte-
ria (the vast majority with P. aeruginosa). Only one of the
seven patients who were operated on twice was chronically
infected. The male–female rate was 20/28 and 27 cases (50%)
were below 18 years of age (range 6–46 years). Thirty-two pa-
tients were dF508 homozygous, 15 patients were dF508 hetero-
zygous and one patient was homozygous for L619S.
Twelve cases received medication with potential influence
on the opacification seen on the CT scan; eight cases had corti-
costeroids and four cases received IV treatment with corticoste-
roids. Two cases received immunosuppressive agents prior to
the CT scan, one in addition to IV steroid treatment and one
in addition to oral steroids. Forty cases underwent surgery
according to the primary criterion (see above), and eight cases
according to the second criterion. Overall, 38 of the 55 cases
had symptoms of CRS according to the SNOT-22 score.
Seven cases only had surgery due to symptoms (criterion 3)
with no hope of improving their lung function (chronically
lung infected or not infected with pathogenic bacteria).
3.2. CT scans
The median period of time between the CT scan and sinus
surgery was 20 days (IQR: 8 to 42 days). The median Lund
Mackay score was 10 (IQR: 7–13) compared with a median
Nair score of 16 (IQR: 11–20). The variability of the distribu-
tion of the CT scores according to Nair and Lund Mackay are
illustrated in Fig. 1.
3.3. Surgical findings
Three hundred seventy-eight out of 544 possible sinuses
(69%) were opened and pus was noticed in 191 of them
(51%). As seen in Table 1 the majority of the maxillary and eth-
moid sinuses were explored. Polyps were found in 30 out of theTable 1
The distribution of macroscopically pus found in the different sinuses.
Unknown no. (%) Pus no. (%) No pus no. (%) Total
Maxillaries 1 (0.9) 85 (77.3) 24 (21.8) 110
Ethmoids 28 (12.7) 80 (36.4) 112 (50.9) 220
Frontals 67 (60.9) 11 (10.0) 28 (25.5) 106
Sphenoids 70 (63.6) 15 (13.6) 23 (20.9) 108
Total 166 (30.2) 191 (34.7) 187 (34.0) 54455 cases (55%). Six out of the seven revision cases had polyps.
In 50% of these cases the patients were less than 18 years old.
Frontal sinus aplasia was noted in 4 cases and sphenoid sinus
aplasia was noted in 2 cases.
3.4. Microbiological samples
Material from 266 out of 544 possible sinuses (49%) was
cultured and pathogenic growth was found in 175 sinuses
(66%). The distribution of the cultures is shown in Table 2.
Twenty sinuses in six patients were sterile. In five of these six
patients other sinuses showed bacteria. Overall, 45 out of the
55 cases (82%) had growth of pathogenic bacteria from one
or more of their sinuses, nine cases (16%) had only non-
pathogenic cultures from their sinuses and one case had no
growth in all cultured sinuses.
P. aeruginosa was cultured from 27 cases (49%) represent-
ing 60% of the pathogenic cases (Table 3). These cases had a
median Nair score of 17 (IQR: 12–20) and a median Lund
Mackay score of 9.5 (IQR: 7–13). The remaining 28 cases
without P. aeruginosa had a median Nair score of 15 (IQR:
10–19) and a median Lund Mackay score of 11 (IQR: 6–13).
The single case with all sterile sinuses had a Nair score of 10
and 7 by the Lund Mackay. The 10 cases without pathogenic
growth had a median Nair score of 14 (IQR: 10–18) and a me-
dian Lund Mackay score of 8.5 (IQR: 6–14), whereas the 45
cases with pathogenic growth had a median Nair score of 16
(IQR: 12–20) and a median Lund Mackay score of 10 (IQR:Burkholderia multivorans (pat.) 2
Stenotrophomonas maltophilia (pat.) 8
Staphylococcus aureus (pat.) 12
Bordetella bronchiseptica (pat.) 1
Aspergillus (pat.) 2
Haemophilus influenza (pat.) 7
Escherichia coli (non-pat.) 1
Enterobacter cloacae (non-pat.) 1
Candida albicans (non-pat.) 2
Coagulase negative staphylococci (non-pat.) 39
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relation to the bacteriology is shown in Fig. 2. The CT scores
are higher in the group with pathogenic growth than in the
groups without pathogenic growth and sterile cultures (Nair
81% higher and Lund Mackay 19% higher). However, this
was not statistical significant in either of the grading systems.
Notably, several sinuses with pathogenic growth had little or
no opacification.
The presence of pus in the sinuses was correlated with the
Nair score. Pus was found in 20% of the sinuses with a Nair
score of 0 or 1 and in 63% of the sinuses with a Nair score of
2 or 3. The relative risk (RR) of finding pus during surgery in
a sinus with a Nair score of 0–1 compared to a sinus with a
Nair score of 2–3 is 0.3 and the relative risk (RR) for no pus
in a sinus with a Nair score of 2–3 is 0.7. No correlation was
found between the presence of pus and the bacteriology
(OR=1.0 and RR=1.0).Fig. 2. A: Nair and Lund Mackay staging of the sinuses correlated to the pathogenic
comprise the osteomeatal complex which is why this system operates with fewer sinu
genic growth. C: Nair and Lund Mackay staging of the sinuses correlated to no gro3.5. Symptom score
All patients who underwent surgery from June 2009 to Feb-
ruary 2010 (28/55) completed the SNOT-22. The mean score
was 22 (range 1–49). Both Nair and Lund Mackay score had
a positive slope of 0.5 indicating that the grade of opacification
correlates with a high symptom score but were not significant
(Nair: P=0.37, Lund Mackay: P=0.56).
4. Discussion
We present the largest published case series of CF patients
who underwent sinus surgery with focus on eradicating patho-
gen bacteria. They all fulfilled a suggested Lund Mackay
score [12] and the EPOS criteria for having CRS [1], which
do not deal with the matter of bacteria in the sinuses. The
high CT scores reflect that most CF patients have a significantgrowth. Nair staging cumulates the anterior and posterior ethmoids and does not
ses. B: Nair and Lund Mackay staging of the sinuses correlated to the nonpatho-
wth after culture.
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This is explained by their diffuse inflammatory sinus disease
with mucosal oedema [13], secretions captured in the sinuses,
sinus polyps and pus from pathogenic or non-pathogenic bacte-
ria. Diagnostic imaging is mandatory prior to surgery because
of the varying anatomy in CF patients, and our results show
that the Nair scoring system offers a better and more nuanced
evaluation of this by grading the opacification. As expected,
CT scans with highly opacified sinuses were associated with
clinical signs of infection (pus), presence of pathogenic bacteria
and CRS symptoms but far from significant because of the var-
iability of the data, thus giving CT scans low specificity. Inter-
estingly, we found that nearly all CF patients had bacteria in
their sinuses and several sinuses with pathogenic bacteria with-
out radiological or clinical signs of inflammation. We suspect
that this percentage is actually higher since sinuses with pus
are more likely to be explored and cultured. As in the lungs,
it is difficult to distinguish between thick CF mucus and pus,
which could be the reason for the cases with negative cultures
in spite of described pus.
In non CF patients it is known that opacified sinuses do not
necessarily reflect sinus disease [20], but it is unknown, espe-
cially in CF patients, whether sinus disease can be present de-
spite a normal CT scan. The immune response in the CF-
sinuses is reduced and they can thereby serve as a reservoir
for pathogenic bacteria, promote their adaptation, and maintain
the deleterious lung infections [11]. Consequently, we believe
that sinus surgery in the future will be more focused on eradi-
cating bacteria from the sinuses [2,11,21–27]. Thus, the deci-
sion of setting CF-patients up for sinus surgery should be a
collaboration between physicians specialised in CF, microbiol-
ogists and ENT specialists. Our results indicate that this deci-
sion should be made without placing great emphasis on the
CT scan, making repeated CT scans redundant. An endoscopic
guided culture from the middle meatus can be taken being in
concordance with sinus aspirates in 86% of adults with CRS
[21] and 83% among children with acute rhinosinusitis [28].
Similarly, the surgeons should create drainage and culture
thoroughly from the sinuses unaffected by the CT scan, since
these results influence the post-operative antibiotic treatment.
A CT scan is the most commonly used tool for pre-surgical
planning. MRI does not use ionising radiation and can differen-
tiate between infectious material and thickened mucosa and
should therefore be kept in mind as an alternative tool to CT
scans [6].
We used the SNOT-22 questionnaire, which is the most
common way to objectively quantify CRS symptoms, being
aware that some symptoms (e.g. cough) are influenced by
other conditions than CRS and that CF patients are known to
underreport symptoms of CRS [21].
The guidelines [1] do not recommend a maximum period be-
tween the CT scan of the paranasal sinuses and sinus surgery in
CF or non-CF patients with CRS. Optimally, the CT scan
should have been performed just prior to surgery. Especially
the fluctuation of the antibiotic therapy and the corticosteroid
treatment alters the clinical and radiological findings over
time. We accepted to include patients who were scanned lessthan 3 months prior to surgery comprising a median period of
time of 20 days between the CT scan and the surgery reflecting
our present waiting period for a non-acute CT-scan.
The paranasal sinuses are normally sterile, but a review
study estimated that only 2.9–23.5% of CF patients have sterile
sinuses [1]. Compared with these studies our data are based on
a larger case series and we had a thorough method of collecting
samples identifying bacteria which is why our results of bacte-
rial sinusitis contribute to the literature.
Guidelines describing how or when to eradicate P. aerugi-
nosa from CF-sinuses are non-existing, neither with surgery
nor with medical treatment [1,10]. We encourage, that such
guidelines are established and included in the EPOS and that
the role of CT and MRI should be addressed.5. Conclusion
No significant correlation between CT scans and CRS-
symptoms, clinical findings or bacteria could be shown in a
large CF-cohort because of the large variability of these data.
CT scans with low scores do not exclude pathogenic bacteria;
thus CT is only required for pre-surgical planning because of
the low specificity.Acknowledgements
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